These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 5272106)

  • 1. Evaluation of L-dopa therapy in Parkinson's disease.
    Mones RJ; Elizan TS; Siegel GJ
    N Y State J Med; 1970 Sep; 70(18):2309-18. PubMed ID: 5272106
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
    van der Drift JH
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L
    Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173
    [No Abstract]   [Full Text] [Related]  

  • 7. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease.
    Blonsky ER; Minnigh EC
    Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of Parkinson's disease with L-dopa].
    Dalle Ore G; Bricolo A; Robotti E; Bazzan A; Mazza C
    Policlinico Prat; 1970 Apr; 77(16):509-24. PubMed ID: 5443873
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of L-dopa therapy in Parkinson's disease.
    Thompson RA; White JC; Echols CL
    Ariz Med; 1970 Jul; 27(7):5-10. PubMed ID: 5432717
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality in patients with Parkinson's disease treated with dopa.
    Singer RB
    J Insur Med; 1992; 24(2):126-7. PubMed ID: 10148480
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-dopa in the treatment of Parkinson's disease. Preliminary report].
    Poch GF
    Prensa Med Argent; 1969 Oct; 56(34):1629-32. PubMed ID: 5405572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of L-dopa in Parkinson's syndrome].
    Ucar S; Eiras J
    Rev Clin Esp; 1971 Feb; 120(3):257-62. PubMed ID: 5568474
    [No Abstract]   [Full Text] [Related]  

  • 14. [L-dopa in Parkinson's syndrome].
    Filho RM; de Karam GM
    Rev Bras Med; 1971 May; 28(5):220-31. PubMed ID: 5563096
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parkinson's disease treated with L-DOPA].
    Berg-Jensen B
    Nord Med; 1971 Dec; 86(48):1440-1. PubMed ID: 5133987
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H
    Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385
    [No Abstract]   [Full Text] [Related]  

  • 18. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA; De la Herrán J
    Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Silent period in patients with Parkinson's disease treated with L-Dopa].
    Palao Sánchez A
    Arch Neurobiol (Madr); 1973; 36(1):47-56. PubMed ID: 4706780
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I
    J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.